Shopping Cart

4D Molecular Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

SKU
GDPH2429578D
READ MORE
USD 250
Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evoluti

READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene delivery vehicles (novel AAV vectors) to deliver genes to any tissue or organ in the body. 4D Molecular Therapeutics develops pipeline products which targets therapeutic areas such as retina, heart, liver, brain, skeletal muscle and lung. The company works in collaboration with other organizations such as Roche and uniQure to develop novel therapies. 4D Molecular Therapeutics is headquartered at Emeryville, California, the US.

4D Molecular Therapeutics Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

4D Molecular Therapeutics Raises USD7 Million in Venture Financing 10

Partnerships 10

4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 10

Licensing Agreements 11

uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 11

Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 12

4D Molecular Therapeutics Enters into Licensing Agreement with Roche 13

Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 13

Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 14

4D Molecular Therapeutics Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Appendix 19

Methodology 19

About GlobalData 19

Contact Us 19

Disclaimer 19


List Of Figure

List of Figures

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8


List Of Table

List of Tables

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 1

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

4D Molecular Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

4D Molecular Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9

4D Molecular Therapeutics Raises USD7 Million in Venture Financing 10

4D Molecular Therapeutics Enters into Agreement with Choroideremia Research Foundation 10

uniQure Enters into Licensing Agreement with 4D Molecular Therapeutics 11

Pfizer Enters into Licensing Agreement with 4D Molecular Therapeutics 12

4D Molecular Therapeutics Enters into Licensing Agreement with Roche 13

Applied Genetic Technologies Enters into Licensing Agreement with 4D Molecular Therapeutics 13

Benitec Biopharma Enters into Licensing Agreement with 4D Molecular Therapeutics 14

4D Molecular Therapeutics Inc, Key Competitors 16

4D Molecular Therapeutics Inc, Key Employees 17

To know more information on Purchase by Section, please send a mail to

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.